RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

Recruiting

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

Sponsor:

AgNovos Healthcare, LLC

Code:

NCT04796350

Conditions

Fragility Fracture

Hip Fractures

Osteoporosis

Eligibility Criteria

Sex: Female

Age: 65+

Healthy Volunteers: Not accepted

Interventions

AGN1 LOEP treatment

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by AgNovos Healthcare, LLC on 2025-01-31.